Bio safety level, Book by Sue E. Huether

Hyderabad, Jan 4 Bharat Biotech Chairman Krishna Ella said on Monday that the company does not deserve the backlash it is receiving in the light of the India's drugs regulator granting its coronavirus vaccine Covaxin approval for emergency use."Don't accuse us of inexperience. We are a global company... have manufactured 16 vaccines," he said, highlighting that "200 per cent honest" clinical trials were conducted.Ella said the company conducts clinical trials not only in India but also many other countries.His comments assume significance as Covaxin has been given an emergency approval despite allegedly only two of the required three trial phases being completed.However, Ella pointed at the number of journal articles Bharat Biotech published and claimed that it was the first to identify Zika virus and file a patent for Zika and Chikungunya viruses.Bharat Biotech was the only company to have a Bio Safety Level 3 (BSL- 3) production facility, he noted."We do 200 per cent honest clinical trials and yet we receive a backlash. If I am wrong, tell me. Some companies have branded me 'water'. I want to deny that. We are scientists," he said.( With inputs from IANS )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Bio Safety Level, NewsFOLLOW

Bio safety level, Latest News

Health :Don't deserve this backlash, says Covaxin maker Bharat Biotech

Hyderabad, Jan 4 Bharat Biotech Chairman Krishna Ella said on Monday that the company does not deserve the ... ...